Fulcrum Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,019
Closed -$2.7M 286
2025
Q1
$2.7M Sell
21,019
-1,054
-5% -$165K 0.52% 51
2024
Q4
$2.58M Sell
22,073
-1,047
-5% -$162K 12.06% 5
2024
Q3
$2.82M Sell
23,120
-620
-3% -$98.8K 6.46% 7
2024
Q2
$2.82M Buy
+23,740
New +$3.53M 8.77% 5

Other funds holding JNJ

Fulcrum Asset Management's JNJ Position: Q1 2026 in Review

Fulcrum Asset Management increased its Johnson & Johnson (JNJ) stake by 8% in Q1 2026, buying an estimated $395K and bringing the position to 22,876 shares worth $5.55M. The position accounts for 0.84% of the portfolio, ranked #34.

Fulcrum Asset Management first reported a position in JNJ in Q2 2025 and has held it in 4 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Fulcrum Asset Management held 22,876 shares of Johnson & Johnson worth $5.55M as of Q1 2026.
  • Fulcrum Asset Management bought 1,697 Johnson & Johnson shares in Q1 2026, an estimated $395K.
  • Johnson & Johnson made up 0.84% of Fulcrum Asset Management's portfolio in Q1 2026, its #34 holding.
  • Fulcrum Asset Management first reported a position in Johnson & Johnson in Q2 2025 and has held it in 4 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.